You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RAS Wild type Metastatic Colorectal Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer, RAS Wild Type Trial in Napoli (Avelumab, Cetuximab)

Completed
  • Metastatic Colorectal Cancer
  • RAS Wild Type
  • Napoli, Italy
    Università della Campania Luigi Vanvitelli
May 4, 2022

New Prognostic Score for Adult RAS Wild-type mCRC Treated With

Active, not recruiting
  • Metastatic Colorectal Cancer
  • RAS Wild-type
  • Freiburg, Baden-Württemberg, Germany
    Praxis für interdisziplinäre Onkologie & Hämatologie
Jul 29, 2022

Metastatic Colon Cancer Trial in Italy (Trifluridine Tipiracil, Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX])

Completed
  • Metastatic Colon Cancer
  • Trifluridine Tipiracil
  • Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX]
  • Monserrato, CA, Italy
  • +7 more
Jul 21, 2022

Colo-rectal Cancer Trial (biological, drug, procedure)

Not yet recruiting
  • Colo-rectal Cancer
  • Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
  • +8 more
  • (no location specified)
Aug 28, 2023

Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab + Envafolimab + mFOLFOXIRI
  • Cetuximab + mFOLFOX6/FOLFIRI
  • (no location specified)
Jul 24, 2023

Vectibix With Chemotherapy for Metastatic Colorectal Cancer

Completed
Has Results
  • Wild-type RAS Metastatic Colorectal Cancer
  • Panitumumab + Chemotherapy
  • (no location specified)
Nov 4, 2022

Metastatic Colorectal Cancer Trial in Australia (Sodium Valproate, Panitumumab, Cetuximab)

Recruiting
  • Metastatic Colorectal Cancer
  • Sodium Valproate
  • +2 more
  • Saint Leonards, New South Wales, Australia
  • +8 more
Jan 22, 2023

Metastatic Colorectal Cancer Trial in Beijing, Tianjin (CMAB009, Irinotecan, Folinic acid)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Beijing, Beijing, China
  • +1 more
Oct 18, 2022

Metastatic Colorectal Cancer Trial in Beijing (fruquintinib plus capecitabine)

Recruiting
  • Metastatic Colorectal Cancer
  • fruquintinib plus capecitabine
  • Beijing, China
    National Center/Cancer Hospital, China Academy of Medical Scienc
Aug 17, 2022

Colorectal Cancer Stage IV Trial in Napoli (Panitumumab)

Completed
  • Colorectal Cancer Stage IV
  • Napoli, Italy
    Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pasc
Apr 6, 2022

Colorectal Cancer, RAS and BRAF Wild-type, Colorectal Tumors Trial in Hangzhou (Anlotinib Hydrochloride, Capecitabine,

Completed
  • Colorectal Cancer
  • +12 more
  • Anlotinib Hydrochloride
  • +2 more
  • Hangzhou, Zhejiang, China
  • +1 more
Jul 12, 2022

Cancer of Colon Trial in Jerusalem (Cetuximab)

Terminated
  • Cancer of Colon
  • Jerusalem, Israel
    Hadassah Ein Kerem
Aug 2, 2022

Metastatic Colorectal Cancer Trial in France (Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, Panitumumab, oxaliplatin,

Recruiting
  • Metastatic Colorectal Cancer
  • Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil
  • Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, irinotecan
  • Avignon, France
  • +5 more
Aug 2, 2022

Metastatic Colorectal Cancer. Real-World Data Analysis.

Completed
  • Metastatic Colorectal Cancer
    • Istanbul, Turkey
      Istanbul Medeniyet University Hospital
    Oct 25, 2021

    Colorectal Cancer Trial in Madrid (FOLFOX regimen, Panitumumab, Bevacizumab)

    Recruiting
    • Colorectal Cancer
    • FOLFOX regimen
    • +3 more
    • Madrid, Spain
      Spanish Cooperative Group for the Treatment of Digestive Tumors
    Mar 8, 2022

    Circulating Tumour DNA Testing in Assessing for Alterations of

    Recruiting
    • Colorectal Cancer
      • Singapore, Singapore
        National University Hospital
      Sep 28, 2021

      Colorectal Tumors Malignant Trial in Shanghai (Tislelizumab Combined With Cetuximab and Irinotecan, Third-line regimens)

      Not yet recruiting
      • Colorectal Neoplasms Malignant
      • Tislelizumab Combined With Cetuximab and Irinotecan
      • Third-line regimens
      • Shanghai, Shanghai, China
        Tianshu Liu
      Apr 18, 2022

      Colorectal Cancer, Metastatic Colorectal Cancer, RAS Wild Type Colorectal Cancer Trial in Nashville (drug, biological, other,

      Recruiting
      • Colorectal Cancer
      • +3 more
      • Glutaminase Inhibitor CB-839
      • +5 more
      • Nashville, Tennessee
        Vanderbilt-Ingram Cancer Center
      Mar 29, 2022

      Cancer Colorectal Trial in Levallois-Perret (Cetuximab, Irinotecan)

      Recruiting
      • Cancer Colorectal
      • Levallois-Perret, France
        Franco-British Hospital - GCS IHFB Cognacq-Jay
      Aug 25, 2021

      Colorectal Cancer Trial in Nanjing, Beijing (Nimotuzumab, Irinotecan)

      Completed
      • Colorectal Cancer
      • Nanjing, Jiangsu, China
      • +1 more
      Mar 3, 2022

      Metastatic Colorectal Cancer Trial in Munich (Irinotecan, Folinic Acid, 5-FU)

      Recruiting
      • Metastatic Colorectal Cancer
      • Munich, Germany
        Klinikum der Universitaet Muenchen - Campus Grosshadern
      Dec 2, 2021

      Metastatic Colorectal Cancer Trial in United States (panitumumab, Randomization to No Panitumumab)

      Active, not recruiting
      • Metastatic Colorectal Cancer
      • Basking Ridge, New Jersey
      • +7 more
      Apr 1, 2022

      Colorectal Cancer, Liver Metastases Trial in Shanghai (mFOLFOX6 + Cetuximab, mFOLFOX 6)

      Not yet recruiting
      • Colorectal Cancer
      • Liver Metastases
      • mFOLFOX6 + Cetuximab
      • mFOLFOX 6
      • Shanghai, China
        Zhongshan hosptial, Fudan University
      Jul 14, 2023

      Metastatic Colorectal Cancer Trial (Cetuximab and irinotecan)

      Not yet recruiting
      • Metastatic Colorectal Cancer
      • Cetuximab and irinotecan
      • (no location specified)
      Jul 26, 2023

      Metastatic Colorectal Cancer Trial in Beijing (Double blind control period A140, Open single period A140)

      Recruiting
      • Metastatic Colorectal Cancer
      • Double blind control period A140
      • Open single period A140
      • Beijing, Beijing, China
      • +1 more
      Apr 8, 2021